-Down to Earth   Study published in The Lancet indicates what the country will need to spend to provide basic cancer screening and care to patients A report published in the international journal, The Lancet, has drawn attention to poor infrastructure and treatment facilities for cancer patients in India, which is leading to high cancer mortality. To deliver even a basic cancer screening and treatment package in rural India, 15 states would need to...

-Live Mint     As a democracy matures, citizens become more willing to trust elected representatives to plan and take steps for the long-term growth and development One common complaint during this election has been that the election commission (EC) has to be consulted before the government and its regulatory agencies take any routine decision. Decisions relating to gas price hikes and bank licences all had to be cleared by the EC, whose over...

-The Indian Express   Political parties must do more than just pay lip service to universal healthcare in their election manifestos. The governance of the public health sector has become more complex than we imagine. To improve overall health, the sector will have to coordinate and collaborate with other sectors, nationally and regionally, and with several stakeholders. There is no sector that does not have an impact (positive or negative) on public health. What...

-The Financial Express   Even in the BJP's Chhattisgarh, the costs of running the PDS outweigh the benefits-Aadhaar is the obvious answer   The first nail in Aadhaar's coffin, it has to be said, was driven in by none other than Nandan Nilekani. The day the father of the UIDAI's Aadhaar decided not to be a technocrat anymore, and chose to become a Congressman, he gave Aadhaar a distinct political flavour. It was now...

-The Hindu A strong whistle-blower protection law in India would expose financial corruption in a way that reinforces ethical business practices In 2013, generic pharmaceutical company Ranbaxy pleaded guilty to seven criminal felonies for drug manufacturing fraud and agreed to cough up an unprecedented $500 million in fines. The case against Ranbaxy was significant not only for being a successful prosecution of a powerful India corporation. It also marked the triumph of Dinesh...